Sentence examples for multiple sclerosis including from inspiring English sources

For anyone with multiple sclerosis, including adolescents, depression may be a factor.

In a large study of the natural history of multiple sclerosis including 1215 patients, the median time to a second clinical episode was 1.9 years (Confavreux C, 2002).

Experimental autoimmune encephalomyelitis in the Biozzi ABH mouse recapitulates the clinical and pathological features of multiple sclerosis including relapse-remitting episodes with inflammatory mediated demyelination and progressive disability with neurodegeneration.

Animal models of multiple sclerosis, including experimental allergic encephalomyelitis (EAE) and the cuprizone-induced demyelination model, have been widely used to explore the effects of ChrY on the sexual dimorphism in disease susceptibility.

Cardinal features of neuropathic pain in multiple sclerosis include hypersensitivity to cutaneous mechanical and thermal stimuli in the distal extremities [ 10, 12- 14].

Several Phase 3 clinical trials and post-marketing studies in multiple sclerosis included visual outcomes as secondary or exploratory outcomes (Table 1).

Two appraisals (for Alzheimer's disease and Multiple Sclerosis) included adjustments to mean utility values to represent the effect of treatment on carers HRQL, and both utilized the same Alzheimer's caregiver data.

Other alterations of purinergic signalling in multiple sclerosis include reduced expression of P2Y12 receptors in the periphery of demyelinated lesions and increased expression of uracil nucleotide/cysteinyl leukotriene receptor, a P2Y-like receptor that is associated with defective myelination during postnatal life (for review, see Burnstock et al., 2011).

The cortical tissue consisted of the medial temporal gyrus of 50 Alzheimer patients (including two AD patients: superior frontal gyrus tissue), 50 multiple sclerosis patients (including six tissues of MS patients from the superior frontal gyrus and one hippocampus) and 58 age and gender matched non-demented controls (all medial temporal gyrus).

In a statement, NHS North Yorkshire and York said it did not "routinely fund the prescribing of Sativex for patients with multiple sclerosis symptoms including spasticity and pain".

As of 2014, nine disease-modifying treatments have been approved by regulatory agencies for relapsing-remitting multiple sclerosis (RRMS) including: interferon beta-1a, interferon beta-1b, glatiramer acetate, mitoxantrone, natalizumab, fingolimod, teriflunomide, dimethyl fumarate and alemtuzumab.